Thus, our EZR-ROS1 lung cancer animal model could be valuable for evaluating the therapeutic potential of these compounds and novel drugs as well as biological features of ROS1-rearranged lung cancer in vivo. This evidence concerns the gene ROS1 and lung carcinoma.